Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

U.S. prosecutors mull anti-racketeering law against Steve Cohen

Thursday, May 23, 2013

From Komfie Manalo, Opalesque Asia – Government investigators are considering using the Racketeer Influenced and Corrupt Organizations Act to pin Steven Cohen and his hedge fund firm SAC Capital in insider trading, various media reported.

The RICO law, which is commonly used by government prosecutors against the mafia, is being considered against Cohen, but legal experts argue that using the tactic would require the approval of the Department of Justice.

According to Reuters, the office of Manhattan U.S. Attorney Preet Bharara and the Department of Justice did not comment on the report.

At least nine former and current SAC employees have been charged by the government in connection with insider trading, including former portfolio manager Mathew Martoma and Michael Steinberg. But Cohen himself has not been formally charged despite being under the probers’ eye for nearly six years.

The fact that investigators are thinking of using RICO against Cohen may show that the government has no strong evidence against the hedge fund manager in connection with the alleged insider trading.

Early this week, it was reported that Cohen had been subpoenaed by a feder......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its